Cargando…

Cyclophilin A Impairs Efferocytosis and Accelerates Atherosclerosis by Overexpressing CD 47 and Down-Regulating Calreticulin

Impairment of efferocytosis in apoptotic macrophages is a known determinant of the severity of atherosclerosis and the vulnerability of plaques to rupture. The precise mechanisms involved in impaired efferocytosis are unclear. Given the well-recognized role of the inflammatory cytokine cyclophilin A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anandan, Vinitha, Thulaseedharan, Thushara, Suresh Kumar, Aishwarya, Chandran Latha, Karthika, Revikumar, Amjesh, Mullasari, Ajit, Kartha, Chandrasekharan C., Jaleel, Abdul, Ramachandran, Surya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700718/ https://www.ncbi.nlm.nih.gov/pubmed/34944106 http://dx.doi.org/10.3390/cells10123598

Ejemplares similares

Cyclophilin A induces macrophage apoptosis and enhances atherosclerotic lesions in high‐fat diet‐fed hyperglycemic rabbits
por: Anandan, Vinitha, et al.
Publicado: (2021)

Cyclophilin A enhances macrophage differentiation and lipid uptake in high glucose conditions: a cellular mechanism for accelerated macro vascular disease in diabetes mellitus
por: Ramachandran, Surya, et al.
Publicado: (2016)

Plasma level of cyclophilin A is increased in patients with type 2 diabetes mellitus and suggests presence of vascular disease
por: Ramachandran, Surya, et al.
Publicado: (2014)

Structure based virtual screening of inhibitors for binding at the allosteric site of HCV RNA dependent RNA polymerase
por: Revikumar, Amjesh, et al.
Publicado: (2012)

CD47 blockade ameliorates autoimmune vasculitis via efferocytosis of neutrophil extracellular traps
por: Shiratori-Aso, Satoka, et al.
Publicado: (2023)

s-cyclophilin is retained intracellularly via a unique COOH-terminal sequence and colocalizes with the calcium storage protein calreticulin
Publicado: (1992)

Proteomics Analysis Reveals Diverse Molecular Characteristics between Endocardial and Aortic-Valvular Endothelium
por: Aneesh Kumar, A., et al.
Publicado: (2021)

Shear Stress Alterations Activate BMP4/pSMAD5 Signaling and Induce Endothelial Mesenchymal Transition in Varicose Veins
por: Chandran Latha, Karthika, et al.
Publicado: (2021)

Evidence of a dysregulated vitamin D endocrine system in SARS-CoV-2 infected patient’s lung cells
por: George, Bijesh, et al.
Publicado: (2021)

Hyperactivation of p21-Activated Kinases in Human Cancer and Therapeutic Sensitivity
por: Sankaran, Deivendran, et al.
Publicado: (2023)

Efferocytosis in the tumor microenvironment
por: Werfel, Thomas A., et al.
Publicado: (2018)

Efferocytosis and autoimmune disease
por: Kawano, Mahiru, et al.
Publicado: (2018)

Efferocytosis in multisystem diseases
por: Zhang, Yifan, et al.
Publicado: (2022)

Efferocytosis and Respiratory Disease
por: Zheng, Wenxue, et al.
Publicado: (2023)

Heat shock protein 47 confers chemoresistance on pancreatic cancer cells by interacting with calreticulin and IRE1α
por: Yoneda, Akihiro, et al.
Publicado: (2021)

Elimination of Cancer Cells in Co-Culture: Role of Different Nanocarriers in Regulation of CD47 and Calreticulin-Induced Phagocytosis
por: Hassan, Eman M., et al.
Publicado: (2023)

Calreticulin and the Heart
por: Groenendyk, Jody, et al.
Publicado: (2022)

Postprandial Metabolism is Impaired in Overweight Normoglycemic Young Adults without Family History of Diabetes
por: Kumar, A. Aneesh, et al.
Publicado: (2020)

Cyclophilins and cyclophilin inhibitors in nidovirus replication
por: de Wilde, Adriaan H., et al.
Publicado: (2018)

A retrospective study on newborn screening for metabolic disorders
por: Singh, Karam Chandrajit, et al.
Publicado: (2022)

The cyclophilins
por: Wang, Ping, et al.
Publicado: (2005)

Cyclophilin
Publicado: (2011)

Modulation of Macrophage Efferocytosis in Inflammation
por: Korns, Darlynn, et al.
Publicado: (2011)

The Role of Efferocytosis in Autoimmune Diseases
por: Abdolmaleki, Fereshte, et al.
Publicado: (2018)

Efferocytosis of Pathogen-Infected Cells
por: Karaji, Niloofar, et al.
Publicado: (2017)

Efferocytosis is impaired in Gaucher macrophages
por: Aflaki, Elma, et al.
Publicado: (2017)

Efferocytosis in the Central Nervous System
por: Zhao, Jiayi, et al.
Publicado: (2021)

The Revelation of Continuously Organized, Co-Overexpressed Protein-Coding Genes with Roles in Cellular Communications in Breast Cancer
por: Paul, Aswathy Mary, et al.
Publicado: (2022)

LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation
por: Ye, Zi-ming, et al.
Publicado: (2019)

Calreticulin: Challenges Posed by the Intrinsically Disordered Nature of Calreticulin to the Study of Its Function
por: Varricchio, Lilian, et al.
Publicado: (2017)

Efferocytosis in oral squamous cell carcinoma
por: Sarode, Gargi S
Publicado: (2016)

Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis
por: Yurdagul, Arif, et al.
Publicado: (2018)

Potential Mechanisms and Effects of Efferocytosis in Atherosclerosis
por: Wang, Lili, et al.
Publicado: (2021)

Efferocytosis and Anthrax: Implications for Bacterial Sepsis?
por: Mytych, Joshua S., et al.
Publicado: (2021)

Efferocytosis during Skeletal Muscle Regeneration
por: Juban, Gaëtan, et al.
Publicado: (2021)

Cellular Responses to the Efferocytosis of Apoptotic Cells
por: Yin, Charles, et al.
Publicado: (2021)

Efferocytosis and Its Role in Inflammatory Disorders
por: Ge, Yun, et al.
Publicado: (2022)

Importance of Efferocytosis in COVID-19 Mortality
por: Erol, Adnan
Publicado: (2022)

Drugging the efferocytosis process: concepts and opportunities
por: Mehrotra, Parul, et al.
Publicado: (2022)

Forkhead box C2 Promoter Variant c.-512C>T Is Associated with Increased Susceptibility to Chronic Venous Diseases
por: Surendran, Sumi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rr3l85te4vnqjkc6rheuhnupoi